Reveals a positive causal relationship between α-Klotho levels and myocardial fractal dimension, suggesting therapeutic targets for cardiovascular diseases.
Myocardial fractal dimension (FD), a marker of myocardial microarchitecture, correlates with cardiac remodeling. The molecular mechanisms linking α-Klotho, a circulating anti-aging protein, to myocardial FD remain unclear. This study investigates the causal relationship between circulating α-Klotho levels and left ventricular trabecular FD using Mendelian randomization (MR) and explores the molecular pathways mediating this association. Data for α-Klotho levels were obtained from the IEU Open GWAS database (N = 4,675), and left ventricular trabecular FD from the UK Biobank (N = 18,096). MR analysis was performed using genetic instruments associated with α-Klotho, applying Maximum Likelihood, MR-Egger, Inverse Variance Weighted (IVW), and other methods. Sensitivity analyses (Leave-One-Out and funnel plots) assessed robustness. Functional Mapping and Annotation (FUMA) and Gene Ontology (GO) enrichment analyses were used to identify biological processes and pathways. MR analysis revealed a significant positive causal relationship between α-Klotho levels and left ventricular trabecular FD in mid-myocardial slices (Slices 5) (OR = 1.003, 95% CI: 1.001–1.005, p = 0.012). No associations were observed in other slices. Functional and pathway analyses highlighted key processes such as fibroblast growth factor signaling, glycosylation, and protein stability. This study provides evidence that α-Klotho influences myocardial FD through growth factor signaling and cellular processes, suggesting potential therapeutic targets for cardiovascular Diseases.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: